CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Sevilla, Spain and 72 other locations
in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases.This study will ana...
Phase 2
Sevilla, Spain and 11 other locations
participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...
Phase 1, Phase 2
Sevilla, Spain and 22 other locations
-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this stud...
Phase 3
Sevilla, Spain and 52 other locations
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
Sevilla, Spain and 16 other locations
the primary and metastatic (or relapsed) tumor will be collected for central analyses, together with blood, serum and plasma samples. Any s ...
Sevilla, Spain and 51 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Seville, Spain and 117 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Sevilla, Spain and 71 other locations
number of mutations per coding area of a tumor genome). The HER2-E and Basal-like profiles have been associated with high mutational burden ...
Phase 2
Sevilla, Spain and 14 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Sevilla, Spain and 43 other locations
Clinical trials
Research sites
Resources
Legal